Klingenstein Fields & Co Has Lowered By $12.45 Million Its Cvs Health (CVS) Stake, Genesee Valley Trust Company Cut By $332,046 Its Jp Morgan Chase & Co (JPM) Stake

May 23, 2017 - By Adrian Erickson

Klingenstein Fields & Co Llc decreased Cvs Health Corp (CVS) stake by 57.66% reported in 2016Q4 SEC filing. Klingenstein Fields & Co Llc sold 159,618 shares as Cvs Health Corp (CVS)’s stock declined 4.23%. The Klingenstein Fields & Co Llc holds 117,226 shares with $9.25 million value, down from 276,844 last quarter. Cvs Health Corp now has $78.84B valuation. The stock rose 1.40% or $1.07 reaching $77.37. About 3.72M shares traded. CVS Health Corp (NYSE:CVS) has declined 24.40% since May 23, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

Genesee Valley Trust Company decreased Jp Morgan Chase & Co (JPM) stake by 10.26% reported in 2016Q4 SEC filing. Genesee Valley Trust Company sold 3,861 shares as Jp Morgan Chase & Co (JPM)’s stock declined 6.04%. The Genesee Valley Trust Company holds 33,762 shares with $2.91 million value, down from 37,623 last quarter. Jp Morgan Chase & Co now has $303.66B valuation. The stock rose 1.02% or $0.86 reaching $85.55. About 5.31 million shares traded. JPMorgan Chase & Co. (NYSE:JPM) has risen 33.74% since May 23, 2016 and is uptrending. It has outperformed by 17.04% the S&P500.

Since January 13, 2017, it had 0 buys, and 10 sales for $21.13 million activity. $568,100 worth of JPMorgan Chase & Co. (NYSE:JPM) shares were sold by BACON ASHLEY. On Tuesday, January 17 Petno Douglas B sold $1.80 million worth of JPMorgan Chase & Co. (NYSE:JPM) or 21,532 shares. $3.01M worth of JPMorgan Chase & Co. (NYSE:JPM) shares were sold by Erdoes Mary E.. Shares for $542,314 were sold by Donnelly John L. Pinto Daniel E also sold $3.40 million worth of JPMorgan Chase & Co. (NYSE:JPM) shares. The insider Smith Gordon sold 65,865 shares worth $5.51 million. $1.09 million worth of stock was sold by Lake Marianne on Tuesday, January 17.

Analysts await JPMorgan Chase & Co. (NYSE:JPM) to report earnings on July, 13. They expect $1.63 earnings per share, up 5.16% or $0.08 from last year’s $1.55 per share. JPM’s profit will be $5.79B for 13.12 P/E if the $1.63 EPS becomes a reality. After $1.65 actual earnings per share reported by JPMorgan Chase & Co. for the previous quarter, Wall Street now forecasts -1.21% negative EPS growth.

Among 25 analysts covering JPMorgan Chase & Co (NYSE:JPM), 14 have Buy rating, 2 Sell and 9 Hold. Therefore 56% are positive. JPMorgan Chase & Co has $100 highest and $52 lowest target. $76.71’s average target is -10.33% below currents $85.55 stock price. JPMorgan Chase & Co had 51 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Underperform” rating given on Monday, February 22 by Portales Partners. The rating was maintained by Barclays Capital on Tuesday, January 3 with “Overweight”. Vining Sparks maintained the stock with “Outperform” rating in Friday, April 28 report. Nomura maintained JPMorgan Chase & Co. (NYSE:JPM) rating on Wednesday, February 24. Nomura has “Neutral” rating and $67 target. The firm earned “Hold” rating on Monday, April 25 by Ertse Group. The firm earned “Neutral” rating on Monday, January 18 by UBS. Jefferies maintained the shares of JPM in report on Monday, October 10 with “Buy” rating. The rating was maintained by BMO Capital Markets with “Outperform” on Thursday, April 14. The stock has “Buy” rating by UBS on Friday, February 5. Vetr downgraded the shares of JPM in report on Friday, August 28 to “Strong-Buy” rating.

Investors sentiment decreased to 0.82 in 2016 Q4. Its down 0.15, from 0.97 in 2016Q3. It is negative, as 69 investors sold JPM shares while 807 reduced holdings. 166 funds opened positions while 553 raised stakes. 2.60 billion shares or 2.27% more from 2.54 billion shares in 2016Q3 were reported. Cincinnati Specialty Underwriters holds 8.79% or 93,000 shares in its portfolio. Putnam Invs Ltd Liability Corp owns 8.44 million shares for 1.76% of their portfolio. Eagle Asset reported 0.83% in JPMorgan Chase & Co. (NYSE:JPM). Maltese Capital Mngmt Limited Liability Corp holds 0.74% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM) for 94,700 shares. Washington stated it has 2.68% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM). Steinberg Glob Asset Management owns 16,672 shares. State Of Wisconsin Board owns 1.12% invested in JPMorgan Chase & Co. (NYSE:JPM) for 3.02M shares. Farmers Merchants Investments owns 100,425 shares for 0.79% of their portfolio. Telemark Asset Mgmt Limited Liability holds 1.88% or 100,000 shares. Fiduciary Trust invested in 300,947 shares or 0.84% of the stock. Cambridge Inc reported 0.32% stake. Tocqueville Asset Mngmt LP holds 0.17% or 153,680 shares. 123,407 were reported by Fdx Advsr. St Johns Inv Com Limited Liability Com holds 1.03% or 14,515 shares. Park Circle Communications holds 0.11% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM) for 1,900 shares.

Among 17 analysts covering CVS Health (NYSE:CVS), 10 have Buy rating, 0 Sell and 7 Hold. Therefore 59% are positive. CVS Health had 27 analyst reports since July 22, 2015 according to SRatingsIntel. On Thursday, December 17 the stock rating was maintained by Oppenheimer with “Outperform”. The firm earned “Overweight” rating on Thursday, March 10 by Barclays Capital. Vetr upgraded the stock to “Buy” rating in Monday, August 24 report. Morgan Stanley downgraded CVS Health Corp (NYSE:CVS) rating on Monday, June 20. Morgan Stanley has “Equal-Weight” rating and $104 target. The stock of CVS Health Corp (NYSE:CVS) has “Outperform” rating given on Wednesday, August 5 by RBC Capital Markets. The firm earned “Buy” rating on Friday, April 28 by Tigress Financial. The rating was maintained by JP Morgan on Monday, November 2 with “Overweight”. The rating was initiated by Robert W. Baird on Friday, January 22 with “Outperform”. The firm has “Strong Buy” rating given on Monday, November 2 by S&P Research. The company was maintained on Thursday, May 12 by Jefferies.

Klingenstein Fields & Co Llc increased United Technologies Corp (NYSE:UTX) stake by 9,539 shares to 314,127 valued at $34.44M in 2016Q4. It also upped Cisco Systems Inc (NASDAQ:CSCO) stake by 27,654 shares and now owns 53,829 shares. Schlumberger Ltd (NYSE:SLB) was raised too.

Investors sentiment decreased to 0.74 in Q4 2016. Its down 0.24, from 0.98 in 2016Q3. It worsened, as 135 investors sold CVS shares while 627 reduced holdings. 127 funds opened positions while 440 raised stakes. 830.51 million shares or 0.72% less from 836.58 million shares in 2016Q3 were reported. Selway Asset holds 2.45% or 51,803 shares. Barrington Strategic Wealth Gru Llc invested in 0.71% or 16,713 shares. Moreover, Citadel Advsr Ltd Liability Corp has 0.03% invested in CVS Health Corp (NYSE:CVS). Connecticut-based Massmutual Trust Fsb Adv has invested 0% in CVS Health Corp (NYSE:CVS). 49,818 were accumulated by Phocas Fincl Corp. Corbyn Mgmt Md stated it has 3.34% in CVS Health Corp (NYSE:CVS). Putnam Fl Investment owns 213,507 shares. Td Capital Mngmt Llc reported 1,284 shares. Harvest Capital Mgmt Incorporated holds 4,695 shares. Union Bancorporation owns 1.68% invested in CVS Health Corp (NYSE:CVS) for 57,239 shares. Banque Pictet Cie Sa accumulated 314,460 shares. Ensemble Capital Mngmt Limited Liability Co holds 57,779 shares. Schmidt P J Mngmt owns 15,166 shares. Bremer Trust Natl Association holds 0.61% or 28,176 shares. 444,554 are held by Johnson Inv Counsel.

Analysts await CVS Health Corp (NYSE:CVS) to report earnings on August, 1. They expect $1.31 EPS, down 0.76% or $0.01 from last year’s $1.32 per share. CVS’s profit will be $1.33B for 14.77 P/E if the $1.31 EPS becomes a reality. After $1.17 actual EPS reported by CVS Health Corp for the previous quarter, Wall Street now forecasts 11.97% EPS growth.